Stories
- ArticleSteatotic (fatty) liver disease in children with obesity and early onset type 2 diabetes
- ArticleRegulators of Inflammation in Human Prediabetes
- ArticleStudy on Tirzepatide's Effects on Liver Disease Markers in Diabetes Patients
- ArticleContinuous Glucose Monitoring–Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-Standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4
- ArticleCurrent Understanding of SNAC as an Absorption Enhancer: the Oral Semaglutide Experience
- ArticleLinks between child BMI and type 2 diabetes are not influenced by educational and lifestyle factors
- ArticleGuideline-Recommended Care Among U.S. Adults With Diabetes
- ArticleMetformin Could Not Be a Diabetes Medicine If It Inhibited Glycerol Phosphate Dehydrogenase
- ArticleConnection between early-life environment and the risk of developing type 1 diabetes
- ArticleGenital infection with SGLT2 inhibitors: effect of cigarette smoking
- ArticleIslet autoimmunity and risk of type 1 diabetes from joint analyses of birth-cohort studies
- ArticleManagement of type 2 diabetes with the first oral GLP-1RA, oral semaglutide
- ArticleRecommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 Diabetes
- ArticleHaving a type 2 diabetes gene changes the characteristics of type 1 diabetes
- Articletype 1 diabetes genetics in Chinese population
- ArticleFeasibility and Acceptability of Ecological Momentary Assessment of Psychosocial Factors and Self-Management Behaviors Among Veterans With Type 2 Diabetes
- ArticleForming new cells to produce more insulin and treat diabetes
- ArticleA Commitment to Serve: In Remembrance of Richard R. Rubin and Harry Keen
- ArticleDiabetes Care journal and progress in the field of diabetes.
- ArticleNew FDA-approved therapy for diabetic foot pain
- ArticleAdipose GRP78, a significant host factor for COVID-19
- ArticleAcute pancreatitis caused by dapagliflozin and other drugs in the SGLT2 inhibitor class.
- ArticleDepression and Diabetes by age among US workers
- ArticleCardiovascular Outcomes Trials of Incretin-Based Therapies
- ArticleEffect of Severe Hypoglycemia on Ischemic Heart Disease during ~ 30 Years of DCCT/EDIC Follow-up
- ArticleGenetic risk for type 2 diabetes and metabolic health among youth
- ArticleA novel mechanism to explain the transition from obesity to diabetes development.
- ArticleMedication adherence in type 2 diabetes patients measured in urine samples
- ArticleMagnesium deficiency increases the risk of cardiovascular disease in diabetic patients
- ArticleClinical trial of omega-3 supplements to treat peripheral neuropathy in type 1 diabetes
- ArticleChildhood Acute Pancreatitis and Diabetes in Adulthood
- ArticleVitamin D Receptor in Islets Downregulated During Diabetes Development
- ArticleMechanism behind the common diabetes risk gene variant KCNJ11-E23K
- ArticleTime in Range: Applications in Primary Care
- ArticleLowering insulin delivery for exercise in type 1 diabetes
- ArticleUniversity of California Diabetes Treatment Patterns: Enabling Precision Care in Large Populations
- ArticleThe Effect of Telemedicine Follow-up Care of Diabetes-Related Foot Ulcers in the Community
- ArticlePrevalence of fatty liver and fibrosis in patients with T2DM in the USA.
- ArticleEffect of High Intensity Interval Training on A1c in overweight or obese adults with type 1 diabetes
- ArticleExpansion of regulatory T cells prevents type 1 diabetes onset by inhibiting islet destruction
- ArticleVPS41 and diabetes
- ArticleOutcomes of Type 2 diabetes of importance to patients
- ArticleSmartMat measures skin temperature daily to predict foot wounds
- ArticleMeasuring medication adherence at the point of care
- ArticleManipulation of dietary amino acids and energy homeostasis
- ArticleMechanism of glucose-stimulated insulin secretion revisited: essential need of redox signaling.
- ArticleWhy exercise is important for the health of your liver.
- ArticleeATP/P2X7R signaling facilitates T1D onset by fueling autoreactive CD8+ cells.